Evidence map›Paper›PMID 33833439›Full record

ReviewNature reviews. Immunology2021

The cGAS-STING pathway as a therapeutic target in inflammatory diseases.

Alexiane Decout, Jason D Katz, Shankar Venkatraman, Andrea Ablasser

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07573735 (An Observational Study on the Correlation Between Circulating Cell-free DNA and Skin Macrophage STING Pathway Activation in Patients With Atopic Dermatitis), which is not on this map. Cited by 1,319 papers.

0numbers the graph read from it
0cells of the map it votes in
1,319citing papers in PubMed
106.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07573735 recruitingnot on this mapstarted 2026, after this paper: background citation

An Observational Study on the Correlation Between Circulating Cell-free DNA and Skin Macrophage STING Pathway Activation in Patients With Atopic Dermatitis

Typeobservational_patient_registrySponsorZhongda HospitalRan2026 to 2026Enrolled80ConditionsAtopic Dermatitis (Eczema)Armsblood sampling
3 · Its place in the literature

Who cites it

1,319 citing papers in PubMed, 2,056 citations in OpenAlex.

  1. Article
  2. Pharmaceutical biology · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. CRISPR/Cas9-based nanodelivery systems for precision gene editing in neuroinflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1,259 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Alexiane DecoutGlobal Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.
Jason D KatzIFM Therapeutics, Boston, MA, USA.
Shankar VenkatramanIFM Therapeutics, Boston, MA, USA.
Andrea AblasserGlobal Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland. andrea.ablasser@epfl.ch.ORCID http://orcid.org/0000-0002-8475-8999
École Polytechnique Fédérale de Lausanne · CHIfm Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cGAS-STING signalling pathway has emerged as a key mediator of inflammation in the settings of infection, cellular stress and tissue damage. Underlying this broad involvement of the cGAS-STING pathway is its capacity to sense and regulate the cellular response towards microbial and host-derived DNAs, which serve as ubiquitous danger-associated molecules. Insights into the structural and molecular biology of the cGAS-STING pathway have enabled the development of selective small-molecule inhibitors with the potential to target the cGAS-STING axis in a number of inflammatory diseases in humans. Here, we outline the principal elements of the cGAS-STING signalling cascade and discuss the general mechanisms underlying the association of cGAS-STING activity with various autoinflammatory, autoimmune and degenerative diseases. Finally, we outline the chemical nature of recently developed cGAS and STING antagonists and summarize their potential clinical applications.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAutophagyCell DeathCell ProliferationDNA, MitochondrialEnzyme InhibitorsGain of Function MutationHumansInflammationInflammation MediatorsMembrane ProteinsModels, BiologicalModels, MolecularNucleotides, CyclicNucleotidyltransferasesAdaptor Proteins, Signal Transducingcyclic guanosine monophosphate-adenosine monophosphateDNA, MitochondrialEnzyme InhibitorsInflammation MediatorsMembrane ProteinsNucleotides, CyclicNucleotidyltransferases

Identifiers

PMID33833439
PMCPMC8029610
OpenAlexW3145334405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.